Elixinol Wellness (ASX:EXL) EBIT per Share : A$-0.01 (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness EBIT per Share?

Elixinol Wellness's EBIT per Share for the six months ended in Dec. 2023 was A$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 53.60% per year. During the past 5 years, the average EBIT per Share Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Elixinol Wellness's EBIT per Share or its related term are showing as below:

ASX:EXL' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -86.6 Med: 40.9 Max: 53.6
Current: 53.6

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Elixinol Wellness was 53.60% per year. The lowest was -86.60% per year. And the median was 40.90% per year.

ASX:EXL's 3-Year EBIT Growth Rate is ranked better than
90.69% of 859 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs ASX:EXL: 53.60

Elixinol Wellness's EBIT for the six months ended in Dec. 2023 was A$-4.07 Mil.

Elixinol Wellness EBIT per Share Historical Data

The historical data trend for Elixinol Wellness's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness EBIT per Share Chart

Elixinol Wellness Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.37

-0.11

-0.04

-0.03

-0.01

Elixinol Wellness Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial							-0.01	-0.02	-0.01	-0.01	-0.01

Elixinol Wellness EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Elixinol Wellness's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-7.436	/	608.680
=	-0.01

Elixinol Wellness's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.07	/	754.477
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

Elixinol Wellness (ASX:EXL) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Elixinol Wellness EBIT per Share Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixinol Wellness (ASX:EXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

ELLXF:USA

Address

680 George Street, Level 12, Sydney, NSW, AUS, 2000

Website

https://www.elixinolwellness.com

Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines